$2.05
-0.11-5.09%
At close: -
$2.04
-0.01000-0.49%
After Hours: Dec 20, 5:12 PM EDT
Comments
Loading...
Innate Pharma (NASDAQ:IPHA) Stock, Earnings Estimates, EPS, And Revenue
Innate Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Sep 12
EPS
$-0.340
Quarterly Revenue
$13.3M
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$24.9M
Analyze the earnings history of Innate Pharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
Innate Pharma (IPHA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Innate Pharma (IPHA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Innate Pharma (NASDAQ:IPHA) reporting earnings?
Innate Pharma (IPHA) is scheduled to report earnings on March 20, 2025. The last reported earnings were for reported on September 12, 2024 for H1.
What were the latest earnings per share (EPS) for Innate Pharma (NASDAQ:IPHA)?
The Actual EPS was $-0.34, which missed the estimate of $0.00.
What were Innate Pharma’s (NASDAQ:IPHA) revenues?
The Actual Revenue was $13.3M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.